Biotest Market capitalization 2024

Biotest Market capitalization

1.65 B EUR

Biotest Dividend yield

0.12 %

Ticker

BIO.DE

ISIN

DE0005227201

WKN

522720

In 2024, Biotest's market cap stood at 1.65 B EUR, a -2.26% increase from the 1.68 B EUR market cap in the previous year.

The Biotest Market capitalization history

YEARREVENUE (undefined EUR)GROSS MARGIN (%)NET INCOME (undefined EUR)
2026e702.3239,91139.74
2025e719.1238,9829.98
2024e642.3643,64-2
2023684.640,94127
2022516.124,20-32.49
2021515.615,65-64.99
2020484.226,87-32.18
2019419.130,73-4.81
2018400.333,67181.38
2017378.135,44-3.9
201640841,52-46.2
2015534.639,08-82.9
201458238,5718.8
2013500.841,4531.6
201244041,9833.1
201142239,7646
2010412.539,8836.6
2009440.248,2325.4
200842351,8025.4
2007326.452,8815.2
2006281.950,3716
2005237.646,939.9
2004217.947,594.6

Biotest Aktienanalyse

What does Biotest do?

Biotest AG is an innovative and successful company that operates in the fields of medicine, pharmacy, and biotechnology. It was founded in 1946 by Dr. Carl Adolf Vorherr in Dreieich near Frankfurt am Main. The company's original focus was on the development, production, and distribution of blood plasma products. In the 1950s, Biotest expanded into the field of transfusion medicine and began to clinically examine and process blood from donors. It became a leading manufacturer of concentrate preparations for the treatment of immune deficiencies and blood coagulation disorders in the 1960s. In the 1970s, the company became a leading manufacturer of monoclonal and polyclonal antibodies and an important research and development facility for biotechnological applications. Biotest today is divided into five research and business areas: Hematology & Immunology, Clinical Immunology, Biotherapeutics, Dermatology, and Research and Development. The company is globally present with locations in Europe, North America, Asia, and South America. It employs over 2,500 people and its products are available in more than 90 countries. It invests in research and development to stay at the forefront of technology and improve global health. Biotest ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Biotest's Market Capitalization

Biotest's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Biotest's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Biotest's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Biotest’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Biotest Stock

What is the current Biotest market capitalization?

The current market capitalization of Biotest is 1.65 B EUR.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Biotest.

How has the market capitalization of Biotest developed in recent years?

The market capitalization of Biotest has increased/decreased by -2.26% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Biotest?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Biotest?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Biotest have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Biotest pay?

Over the past 12 months, Biotest paid a dividend of 0.05 EUR . This corresponds to a dividend yield of about 0.12 %. For the coming 12 months, Biotest is expected to pay a dividend of 0 EUR.

What is the dividend yield of Biotest?

The current dividend yield of Biotest is 0.12 %.

When does Biotest pay dividends?

Biotest pays a quarterly dividend. This is distributed in the months of June, June, June, September.

How secure is the dividend of Biotest?

Biotest paid dividends every year for the past 2 years.

What is the dividend of Biotest?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Biotest located?

Biotest is assigned to the 'Health' sector.

Wann musste ich die Aktien von Biotest kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Biotest from 9/4/2017 amounting to 0.05 EUR, you needed to have the stock in your portfolio before the ex-date on 8/31/2017.

When did Biotest pay the last dividend?

The last dividend was paid out on 9/4/2017.

What was the dividend of Biotest in the year 2023?

In the year 2023, Biotest distributed 0 EUR as dividends.

In which currency does Biotest pay out the dividend?

The dividends of Biotest are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Biotest

Our stock analysis for Biotest Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biotest Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.